Analgesic prescription patterns among hemodialysis patients in the DOPPS: Potential for underprescription

Kidney International

Volumn 65, Issue 6, 2004, Pages 2419-2425

  Bailie, George R ^a   Mason, Nancy A ^b   Bragg Gresham, Jennifer L ^b   Gillespie, Brenda W ^b   Young, Eric W ^b  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b NONE

Author keywords

Analgesics; Hemodialysis; Narcotic analgesics; Nonnarcotic analgesics; Pain control; Prescription practices

Indexed keywords

ANALGESIC AGENT; CYCLOOXYGENASE 2; DEXTROPROPOXYPHENE; HYDROCODONE; IBUPROFEN; INDOMETACIN; LAXATIVE; MORPHINE; NAPROXEN; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; PARACETAMOL;

ADULT; AGED; ANALGESIA; ARTICLE; CANCER; CARDIOVASCULAR DISEASE; CELLULITIS; CHRONIC KIDNEY DISEASE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL DISEASE; GROUPS BY AGE; HEMODIALYSIS; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LUNG DISEASE; MALE; MENTAL DISEASE; PAIN; PRESCRIPTION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK;

EID: 2442638777     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00658.x     Document Type: Article

References (36)

1. SARAN R, DYKSTRA DM, WOLFE RA, et al: Association between vascular access failure and the use of specific drugs: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 40:1255-1263, 2002
2. DAVIES G, KINGSWOOD C, STREET M: Pharmacokinetics of opioids in renal dysfunction. Clin Pharmacokinet 31:410-422, 1996
3. PAULI-MAGNUS C, HOFFMANN U, MIKUS G, et al: Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 14:903-909, 1999
4. STOCK SL, CATALANO G, CATALANO MC: Meperidine associated mental status changes in a patient with chronic renal failure. J Fla Med Assoc 83:315-319, 1996
5. GIBSON TP, GIACOMINI KM, BRIGGS WA, et al: Propoxyphene and norpropoxyphene plasma concentrations in the anephric patient. Clin Pharmacol Ther 27:665-670, 1980
6. WEIGERT AL, SCHAFER AI: Uremic bleeding: Pathogenesis and therapy. Am J Med Sci 316:94-104, 1998
7. SCHULMAN S, HENRIKSSON K: Interaction of ibuprofen and warfarin on primary haemostasis. Br J Rheum 28:46-49, 1989
8. ANGST MS, BUHRER M, LOTSCH J: Insidious intoxication after morphine treatment in renal failure: Delayed onset of morphine-6-glucuronide action. Anesthesiology 92:1473-1476, 2000
9. GUO X, NZERUE C: How to prevent, recognize, and treat drug-induced nephrotoxicity. Cleve Clin J Med 69:289-290, 293-294, 296-297, 2002
10. KURELLA M, BENNETT WM, CHERTOW GM: Analgesia in patients with end-stage renal disease: A review of available evidence. Am J Kidney Dis 42:217-228, 2002
11. JACOX A, CARR DB, PAYNE R: New clinical practice guidelines for the management of pain in patients with cancer. N Engl J Med 330:651-655, 1994
12. HEINRICH WL, AGODOA LE, BARRETT B, et al: Analgesics and the kidney: Summary and recommendations to the scientific advisory board of the National Kidney Foundation from an ad hoc committee of the National Kidney Foundation. Am J Kidney Dis 27:162-165, 1996
13. FAINSINGER RL, DAVISON SN, BRENNEIS C: A supportive care model for dialysis patients. Palliat Med 17:81-82, 2003
14. ANDERSON KO, RICHMAN SP, HURLEY J, et al: Cancer pain management among underserved minority outpatients: Perceived needs and barriers to optimal control. Cancer 94:2295-2304, 2002
15. CLEELAND CS: Undertreatment of cancer pain in elderly patients. JAMA 279:1914-1915, 1998
16. CLEELAND CS, GONIN R, HATFIELD AK, et al: Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 330:592-596, 1994
17. BERNABEI R, GAMBASSI G, LAPANE K, et al: Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology. JAMA 279:1877-1882, 1998
18. SESSO R, RODRIGUES-NETO JF, FERRAZ MB: Impact of socioeconomic status on the quality of life of ESRD patients. Am J Kidney Dis 41:186-195, 2003
19. HAN SY, YOON JW, JO SK, et al: Insomnia in diabetic hemodialysis patients. Prevalence and risk factors by a multicenter study. Nephron 92:127-132, 2002
20. SANNER BM, TEPEL M, ESSER M, et al: Sleep-related breathing disorders impair quality of life in hemodialysis recipients. Nephrol Dial Transplant 17:1260-1265, 2002
21. BLAKE C, CODD MB, CASSIDY A, O'MEARA YM: Physical function, employment and quality of life in end-stage renal disease. J Nephrol 13:142-149, 2000
22. UNITED STATES RENAL DATA SYSTEM: 1998 Annual Data Report. Medication use among dialysis patients in the DMMS. Am J Kidney Dis 32 (Suppl 1):S60-S68, 1998
23. MANLEY HJ, BAILIE GR, GRABE DW: Comparing medication use in two hemodialysis units against national dialysis databases. Am J Health-Syst Pharm 57:902-906, 2000
24. MANLEY HJ, MCCLARAN ML, OVERBAY DK, et al: Factors associated with medication-related problems in ambulatory hemodialysis patients. Am J Kidney Dis 41:386-393, 2003
25. GOODKIN DA, MAPES DL, HELD PJ: The Dialysis Outcomes and Practice Patterns Study (DOPPS): How can we improve the care of hemodialysis patients? Semin Dial 14:157-159, 2001
26. YOUNG EW, GOODKIN DA, MAPES DL, et al: The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis study. Kidney Int 57(Suppl 74):S74-S81, 2000
27. SAS TECHNICAL SUPPORT. GLIMMIX: A SAS macro for fitting generalized linear mixed models using Proc Mixed and the Output Delivery System (ODS). Available at http://ftp.sas.com/ techsup/download/stat/glmm800.html, accessed July 11, 2003
28. KLEIN JP, MOESCHBERGER ML (editors): Survival Analysis: Techniques for Censored and Truncated Data, New York, Springer-Verlag, 1997
29. WARE JE, SNOW KK, KOSINSKI M, GANDEK B: SF-36 Health Survey: Manual & Interpretation Guide, Boston, The Health Institute, New England Medical Center, 1997
30. WUERTH D, FINKELSTEIN SH, CIARCIA J, et al: Identification and treatment of depression in a cohort of patients maintained on chronic peritoneal dialysis. Am J Kidney Dis 37:1011-1017, 2001
31. YASUDA G, SHIBATA K, TAKIZAWA T, et al: Prevalence of constipation in continuous ambulatory peritoneal dialysis patients and comparison with hemodialysis patients. Am J Kidney Dis 39:1292-1299, 2002
32. BRATER DC: Effects of nonsteroidal anti-inflammatory drugs on renal function: Focus on cyclooxygenase-2 selective inhibition. Am J Med 107 (Suppl 6A):65S-71S, 1999
33. PERAZELLA MA: Cox 2 selective inhibitors: Analysis of the renal effects. Expert Opin Drug Saf 1:53-64, 2002
34. SWAN SK, RUDY DW, LASSETER KC, et al: Effects of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. Ann Intern Med 133:1-9, 2000
35. DIAZ-BUXO JA, LOWRIE EG, LEW NL, et al: Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance. Am J Kidney Dis 33:523-534, 1999
36. JOINT COMMISSION ON ACCREDITATION OF HEALTHCARE ORGANIZATIONS: Comprehensive Accreditation Manual for Behavioral Health Care Manual, 2004